nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirenzepine—Oxcarbazepine—CYP3A5—prostate cancer	0.0183	0.112	CrCbGaD
Pirenzepine—Thioproperazine—SLC22A1—prostate cancer	0.0168	0.102	CrCbGaD
Pirenzepine—Thiothixene—SLC22A1—prostate cancer	0.0165	0.101	CrCbGaD
Pirenzepine—Azatadine—CYP3A4—prostate cancer	0.0149	0.0907	CrCbGaD
Pirenzepine—Oxcarbazepine—CYP2C19—prostate cancer	0.0125	0.076	CrCbGaD
Pirenzepine—Mirtazapine—ADRB2—prostate cancer	0.0124	0.0755	CrCbGaD
Pirenzepine—Olanzapine—CYP2C19—prostate cancer	0.01	0.061	CrCbGaD
Pirenzepine—Clozapine—CYP1B1—prostate cancer	0.00965	0.0588	CrCbGaD
Pirenzepine—Oxcarbazepine—CYP3A4—prostate cancer	0.00794	0.0484	CrCbGaD
Pirenzepine—Clozapine—CYP2A6—prostate cancer	0.00744	0.0453	CrCbGaD
Pirenzepine—Mirtazapine—CYP3A4—prostate cancer	0.00679	0.0413	CrCbGaD
Pirenzepine—Olanzapine—CYP3A4—prostate cancer	0.00637	0.0388	CrCbGaD
Pirenzepine—Prochlorperazine—CYP3A4—prostate cancer	0.00551	0.0336	CrCbGaD
Pirenzepine—Clozapine—CYP2E1—prostate cancer	0.00528	0.0322	CrCbGaD
Pirenzepine—Clozapine—CYP2C19—prostate cancer	0.00523	0.0319	CrCbGaD
Pirenzepine—Clozapine—CYP1A1—prostate cancer	0.00521	0.0317	CrCbGaD
Pirenzepine—Clozapine—CYP3A4—prostate cancer	0.00333	0.0203	CrCbGaD
Pirenzepine—CHRM5—Signaling Pathways—GNRH1—prostate cancer	0.000801	0.000958	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PTHLH—prostate cancer	0.000796	0.000953	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—ITPR1—prostate cancer	0.000789	0.000944	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—JUP—prostate cancer	0.00078	0.000933	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—WNT4—prostate cancer	0.00078	0.000933	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—LPAR1—prostate cancer	0.000775	0.000928	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GRP—prostate cancer	0.000775	0.000928	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PLCB2—prostate cancer	0.000768	0.000918	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—LRP2—prostate cancer	0.000768	0.000918	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—ADRB2—prostate cancer	0.000758	0.000907	CbGpPWpGaD
Pirenzepine—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—prostate cancer	0.000758	0.000906	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CX3CL1—prostate cancer	0.000753	0.000901	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—P4HB—prostate cancer	0.000753	0.000901	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ANXA1—prostate cancer	0.000749	0.000896	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—RALBP1—prostate cancer	0.000744	0.00089	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MC2R—prostate cancer	0.000744	0.00089	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—VAV3—prostate cancer	0.000739	0.000884	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HIST1H2BG—prostate cancer	0.000739	0.000884	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GRB7—prostate cancer	0.000732	0.000876	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PDE4D—prostate cancer	0.000732	0.000876	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PTHLH—prostate cancer	0.000723	0.000865	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—ITPR1—prostate cancer	0.000717	0.000858	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HIST1H4H—prostate cancer	0.000714	0.000854	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—CXCL8—prostate cancer	0.000713	0.000853	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.00071	0.00085	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PRKACB—prostate cancer	0.000708	0.000847	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—CALCA—prostate cancer	0.000701	0.000839	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GNG5—prostate cancer	0.000697	0.000833	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PPP3CA—prostate cancer	0.00069	0.000826	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—CXCL12—prostate cancer	0.000685	0.000819	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ANXA1—prostate cancer	0.00068	0.000814	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PENK—prostate cancer	0.000663	0.000793	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000659	0.000789	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	0.000651	0.000779	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CALCA—prostate cancer	0.000637	0.000762	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GHR—prostate cancer	0.000633	0.000757	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—PIK3CA—prostate cancer	0.000632	0.000756	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PRKCQ—prostate cancer	0.000625	0.000748	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CXCL12—prostate cancer	0.000622	0.000744	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.000615	0.000736	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PTHLH—prostate cancer	0.000607	0.000726	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—TGFBR1—prostate cancer	0.000607	0.000726	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NRP1—prostate cancer	0.000606	0.000726	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—AKR1C3—prostate cancer	0.000597	0.000714	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PRKACB—prostate cancer	0.000594	0.000711	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ADRB2—prostate cancer	0.000588	0.000703	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—THBS1—prostate cancer	0.000579	0.000693	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PPP3CA—prostate cancer	0.000579	0.000693	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—TP53—prostate cancer	0.000577	0.00069	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—VAV3—prostate cancer	0.000573	0.000686	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ANXA1—prostate cancer	0.000571	0.000683	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PRKCQ—prostate cancer	0.000568	0.000679	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.000565	0.000676	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—VIP—prostate cancer	0.000564	0.000675	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GNRH1—prostate cancer	0.000564	0.000675	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PRKCZ—prostate cancer	0.00056	0.00067	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ITPR1—prostate cancer	0.000556	0.000665	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PIK3CG—prostate cancer	0.000547	0.000655	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—LPAR1—prostate cancer	0.000546	0.000653	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GRP—prostate cancer	0.000546	0.000653	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—FGFR4—prostate cancer	0.000541	0.000647	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PARP1—prostate cancer	0.000541	0.000647	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—LRP2—prostate cancer	0.00054	0.000647	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PLCB2—prostate cancer	0.00054	0.000647	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CALCA—prostate cancer	0.000534	0.000639	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ADRB2—prostate cancer	0.000534	0.000638	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—P4HB—prostate cancer	0.00053	0.000634	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CX3CL1—prostate cancer	0.00053	0.000634	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—IL6—prostate cancer	0.000528	0.000632	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CXCL12—prostate cancer	0.000522	0.000624	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—VAV3—prostate cancer	0.00052	0.000623	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HIST1H2BG—prostate cancer	0.00052	0.000623	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GRB7—prostate cancer	0.000516	0.000617	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PDE4D—prostate cancer	0.000516	0.000617	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ITPR1—prostate cancer	0.000505	0.000604	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HIST1H4H—prostate cancer	0.000502	0.000601	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—CXCL8—prostate cancer	0.000502	0.000601	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.0005	0.000599	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PIK3CG—prostate cancer	0.000497	0.000595	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CASP9—prostate cancer	0.000491	0.000588	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GNG5—prostate cancer	0.00049	0.000587	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PIK3CD—prostate cancer	0.000481	0.000576	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PRKCQ—prostate cancer	0.000476	0.00057	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—NGFR—prostate cancer	0.000476	0.00057	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MAP3K7—prostate cancer	0.000471	0.000563	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—FGF10—prostate cancer	0.000452	0.000541	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ADRB2—prostate cancer	0.000448	0.000536	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—JAK2—prostate cancer	0.000442	0.000528	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—MAP2K1—prostate cancer	0.00044	0.000526	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PIK3CD—prostate cancer	0.000437	0.000523	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—VAV3—prostate cancer	0.000437	0.000522	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—TGFBR2—prostate cancer	0.00043	0.000515	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PTHLH—prostate cancer	0.000427	0.000511	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—TGFBR1—prostate cancer	0.000427	0.000511	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ITPR1—prostate cancer	0.000423	0.000507	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—AKR1C3—prostate cancer	0.00042	0.000503	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PIK3CB—prostate cancer	0.000419	0.000502	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PRKACB—prostate cancer	0.000418	0.0005	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PPP3CA—prostate cancer	0.000408	0.000488	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—THBS1—prostate cancer	0.000408	0.000488	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IGF1R—prostate cancer	0.000405	0.000484	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—CXCL8—prostate cancer	0.000403	0.000482	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ANXA1—prostate cancer	0.000402	0.000481	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—JAK2—prostate cancer	0.000401	0.00048	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PRKCZ—prostate cancer	0.000394	0.000472	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—LPL—prostate cancer	0.000388	0.000464	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PIK3CG—prostate cancer	0.000385	0.000461	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—IL2—prostate cancer	0.000385	0.000461	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PDGFRB—prostate cancer	0.000385	0.00046	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PIK3CB—prostate cancer	0.000381	0.000456	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PARP1—prostate cancer	0.000381	0.000456	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—FGFR4—prostate cancer	0.000381	0.000456	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CALCA—prostate cancer	0.000376	0.00045	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ITGB3—prostate cancer	0.000375	0.000449	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CXCL12—prostate cancer	0.000367	0.00044	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CXCL8—prostate cancer	0.000366	0.000438	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ERBB3—prostate cancer	0.000364	0.000435	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—FGFR2—prostate cancer	0.000363	0.000434	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PIK3CG—prostate cancer	0.00035	0.000419	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—IL2—prostate cancer	0.00035	0.000419	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—TERT—prostate cancer	0.000349	0.000417	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CASP9—prostate cancer	0.000346	0.000414	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PIK3CD—prostate cancer	0.000339	0.000405	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PRKCQ—prostate cancer	0.000335	0.000401	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NGFR—prostate cancer	0.000335	0.000401	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HIF1A—prostate cancer	0.000333	0.000399	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MAP3K7—prostate cancer	0.000331	0.000396	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—LEP—prostate cancer	0.000325	0.000389	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CAV1—prostate cancer	0.000322	0.000386	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—KDR—prostate cancer	0.000319	0.000381	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—FGF10—prostate cancer	0.000319	0.000381	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ADRB2—prostate cancer	0.000315	0.000377	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—JAK2—prostate cancer	0.000311	0.000372	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ESR1—prostate cancer	0.000311	0.000372	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—MAP2K1—prostate cancer	0.00031	0.000371	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PIK3CD—prostate cancer	0.000308	0.000368	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—VAV3—prostate cancer	0.000307	0.000368	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—BAD—prostate cancer	0.000303	0.000363	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—TGFBR2—prostate cancer	0.000303	0.000363	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ITPR1—prostate cancer	0.000298	0.000357	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PIK3CB—prostate cancer	0.000295	0.000353	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—APC—prostate cancer	0.000294	0.000351	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PIK3CG—prostate cancer	0.000294	0.000351	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—EGF—prostate cancer	0.00029	0.000347	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IRS1—prostate cancer	0.00029	0.000347	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IGF1R—prostate cancer	0.000285	0.000341	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—CXCL8—prostate cancer	0.000284	0.00034	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—JAK2—prostate cancer	0.000282	0.000338	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GSK3B—prostate cancer	0.000282	0.000337	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—INS—prostate cancer	0.000278	0.000333	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—LPL—prostate cancer	0.000273	0.000327	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CREBBP—prostate cancer	0.000272	0.000326	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—IL2—prostate cancer	0.000271	0.000325	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PDGFRB—prostate cancer	0.000271	0.000324	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IGF1—prostate cancer	0.000269	0.000322	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PIK3CB—prostate cancer	0.000268	0.000321	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—EGFR—prostate cancer	0.000268	0.00032	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ITGB3—prostate cancer	0.000264	0.000316	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MAP2K1—prostate cancer	0.00026	0.000311	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PIK3CD—prostate cancer	0.000258	0.000309	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CXCL8—prostate cancer	0.000258	0.000308	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ERBB3—prostate cancer	0.000256	0.000306	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PIK3CA—prostate cancer	0.000256	0.000306	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—FGFR2—prostate cancer	0.000256	0.000306	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—SERPINE1—prostate cancer	0.000255	0.000305	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—KRAS—prostate cancer	0.000253	0.000302	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—FGF2—prostate cancer	0.000247	0.000296	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—IL2—prostate cancer	0.000246	0.000295	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—TERT—prostate cancer	0.000245	0.000294	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—NOS3—prostate cancer	0.000244	0.000292	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—JAK2—prostate cancer	0.000237	0.000283	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HIF1A—prostate cancer	0.000235	0.000281	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PIK3CA—prostate cancer	0.000232	0.000278	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MDM2—prostate cancer	0.000231	0.000277	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—LEP—prostate cancer	0.000229	0.000274	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ERBB2—prostate cancer	0.000228	0.000273	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CAV1—prostate cancer	0.000227	0.000272	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PIK3CB—prostate cancer	0.000225	0.000269	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—KDR—prostate cancer	0.000224	0.000269	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ESR1—prostate cancer	0.000219	0.000262	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CXCL8—prostate cancer	0.000216	0.000259	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—BAD—prostate cancer	0.000213	0.000255	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CDKN1B—prostate cancer	0.000211	0.000253	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—AKT1—prostate cancer	0.000209	0.00025	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CASP3—prostate cancer	0.000207	0.000248	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	0.000207	0.000247	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—APC—prostate cancer	0.000207	0.000247	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IL2—prostate cancer	0.000207	0.000247	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—IL6—prostate cancer	0.000206	0.000246	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—EGF—prostate cancer	0.000204	0.000245	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IRS1—prostate cancer	0.000204	0.000245	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CCND1—prostate cancer	0.000201	0.000241	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CTNNB1—prostate cancer	0.000199	0.000239	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GSK3B—prostate cancer	0.000198	0.000237	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—INS—prostate cancer	0.000196	0.000234	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MMP9—prostate cancer	0.000196	0.000234	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CDKN1A—prostate cancer	0.000195	0.000233	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PTEN—prostate cancer	0.000194	0.000233	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CREBBP—prostate cancer	0.000192	0.000229	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—AKT1—prostate cancer	0.00019	0.000227	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IGF1—prostate cancer	0.000189	0.000227	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—EGFR—prostate cancer	0.000188	0.000225	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—EP300—prostate cancer	0.000185	0.000222	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	0.000183	0.000219	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	0.000182	0.000217	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—SRC—prostate cancer	0.00018	0.000216	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	0.00018	0.000215	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	0.00018	0.000215	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—KRAS—prostate cancer	0.000178	0.000213	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—VEGFA—prostate cancer	0.000176	0.00021	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—FGF2—prostate cancer	0.000174	0.000208	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—STAT3—prostate cancer	0.000174	0.000208	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NOS3—prostate cancer	0.000172	0.000205	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—JAK2—prostate cancer	0.000167	0.0002	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	0.000163	0.000196	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MDM2—prostate cancer	0.000163	0.000195	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MYC—prostate cancer	0.000162	0.000193	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—TGFB1—prostate cancer	0.000161	0.000193	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ERBB2—prostate cancer	0.000161	0.000192	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	0.000158	0.00019	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—EGFR—prostate cancer	0.000158	0.000189	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CXCL8—prostate cancer	0.000152	0.000182	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—KRAS—prostate cancer	0.000149	0.000179	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	0.000149	0.000178	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	0.000147	0.000176	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CASP3—prostate cancer	0.000146	0.000174	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IL2—prostate cancer	0.000145	0.000174	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—IL6—prostate cancer	0.000145	0.000173	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CCND1—prostate cancer	0.000142	0.00017	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	0.00014	0.000168	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MMP9—prostate cancer	0.000138	0.000165	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	0.000137	0.000164	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PIK3CA—prostate cancer	0.000137	0.000164	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PTEN—prostate cancer	0.000137	0.000164	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—AKT1—prostate cancer	0.000134	0.00016	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—TP53—prostate cancer	0.000133	0.000159	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—EP300—prostate cancer	0.000131	0.000156	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—SRC—prostate cancer	0.000127	0.000152	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	0.000124	0.000148	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—STAT3—prostate cancer	0.000122	0.000146	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IL6—prostate cancer	0.000121	0.000145	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MYC—prostate cancer	0.000114	0.000136	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	0.000113	0.000136	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—AKT1—prostate cancer	0.000112	0.000134	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—EGFR—prostate cancer	0.000111	0.000133	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—KRAS—prostate cancer	0.000105	0.000126	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	9.66e-05	0.000116	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—TP53—prostate cancer	9.34e-05	0.000112	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IL6—prostate cancer	8.55e-05	0.000102	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—AKT1—prostate cancer	7.89e-05	9.44e-05	CbGpPWpGaD
